The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 1×
“CpG-rich oligonucleotides, for example, bind to Toll-like receptor 9 ( TLR9 ) and induce activation of DCs, which in turn stimulate the immune respons”
BackgroundPrevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Taking dendritic cells into medicine
Steinman, R. M., & Banchereau, J. (2007) · Nature · doi:10.1038/nature06175 · Cited by 2,127
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Modulation of tryptophan catabolism by regulatory T cells
Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M.-L., & Puccetti, P. (2003) · Nature Immunology · doi:10.1038/ni1003 · Cited by 1,374
The Molecular Cell Biology of Interferon-gamma and its Receptor
Farrar, M. A., & Schreiber, R. D. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.003035 · Cited by 1,341
Munn, D. H., Sharma, M. D., Baban, B., Harding, H. P., Zhang, Y., Ron, D., & Mellor, A. L. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.013 · Cited by 1,272
Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., & Gately, M. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1223 · Cited by 1,197
CTLA-4–Ig regulates tryptophan catabolism in vivo
Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., et al. (2002) · Nature Immunology · doi:10.1038/ni846 · Cited by 1,161
Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., & Ferrara, G. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020121 · Cited by 1,133
Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., & Prendergast, G. C. (2005) · Nature Medicine · doi:10.1038/nm1196 · Cited by 1,064
Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6752 · Cited by 1,047
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
Terness, P., Bauer, T. M., Röse, L., Dufter, C., Watzlik, A., Simon, H., & Opelz, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020052 · Cited by 937
Self-citationMonoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
Melero, I., Shuford, W. W., Newby, S. A., Aruffo, A., Ledbetter, J. A., Hellström, K. E., Mittler, R. S., & Chen, L. (1997) · Nature Medicine · doi:10.1038/nm0697-682 · Cited by 898
Pfefferkorn, E. R. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.3.908 · Cited by 854
Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., & Mellor, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21583 · Cited by 852
Recombinant IL-12 administration induces tumor regression in association with IFN- gamma production.
Nastala, C. L., Edington, H. D., McKinney, T. G., Tahara, H., Nalesnik, M. A., Brunda, M. J., Gately, M. K., Wolf, S. F., Schreiber, R. D., Storkus, W. J., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.4.1697 · Cited by 780
Tryptophan and the immune response
Moffett, J. R., & Namboodiri, M. A. (2003) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2003.t01-1-01177.x · Cited by 760
Hwu, P., Du, M. X., Lapointe, R., Do, M., Taylor, M. W., & Young, H. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3596 · Cited by 739
Speiser, D. E., Líénard, D., Rufer, N., Rubio‐Godoy, V., Rimoldi, D., Lejeune, F. J., Krieg, A. Μ., Cerottini, J., & Romero, P. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523373 · Cited by 640
Brandacher, G., Perathoner, A., Ladurner, R., Schneeberger, S., Obrist, P., Winkler, C., Werner, E. R., Werner-Felmayer, G., Weiss, H. G., G√∂bel, G., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1966 · Cited by 614
Self-citationHou, D.-Y., Muller, A. J., Sharma, M. D., DuHadaway, J., Banerjee, T., Johnson, M., Mellor, A. L., Prendergast, G. C., & Munn, D. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2925 · Cited by 586
Cutting Edge: Role of Toll-Like Receptor 9 in CpG DNA-Induced Activation of Human Cells
Takeshita, F., Leifer, C. A., Gursel, I., Ishii, K. J., Takeshita, S., Gursel, M., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3555 · Cited by 570
Takikawa, O., Kuroiwa, T., Yamazaki, F., & Kido, R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77982-4 · Cited by 472
Metz, R., DuHadaway, J. B., Kamasani, U., Laury-Kleintop, L., Muller, A. J., & Prendergast, G. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1872 · Cited by 467
Mellor, A. L., Baban, B., Chandler, P., Marshall, B., Jhaver, K., Hansen, A., Koni, P. A., Iwashima, M., & Munn, D. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1652 · Cited by 455
Chen, W., Liang, X., Peterson, A. J., Munn, D. H., & Blazar, B. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5396 · Cited by 453
Sugimoto, H., Oda, S.-I., Otsuki, T., Hino, T., Yoshida, T., & Shiro, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508996103 · Cited by 441
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice
Ball, H. J., Sanchez-Perez, A., Weiser, S., Austin, C. J. D., Astelbauer, F., Miu, J., McQuillan, J. A., Stocker, R., Jermiin, L. S., & Hunt, N. H. (2007) · Gene · doi:10.1016/j.gene.2007.04.010 · Cited by 434
Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division
Lee, G. K., Park, H. J., Macleod, M., Chandler, P., Munn, D. H., & Mellor, A. L. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01526.x · Cited by 432
Chiesa, M. D., Carlomagno, S., Frumento, G., Balsamo, M., Cantoni, C., Conte, R., Moretta, L., Moretta, A., & Vitale, M. (2006) · Blood · doi:10.1182/blood-2006-03-006700 · Cited by 399
Indoleamine 2,3‐dioxygenase in T‐cell tolerance and tumoral immune escape
Katz, J. B., Muller, A. J., & Prendergast, G. C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00610.x · Cited by 398
Curti, A., Pandolfi, S., Valzasina, B., Aluigi, M., Isidori, A., Ferri, E., Salvestrini, V., Bonanno, G., Rutella, S., Durelli, I., et al. (2007) · Blood · doi:10.1182/blood-2006-07-036863 · Cited by 396
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation
Braun, D., Longman, R. S., & Albert, M. L. (2005) · Blood · doi:10.1182/blood-2005-03-0979 · Cited by 391
Botanicals in Cancer Chemoprevention
Jung Park, E., & Pezzuto, J. M. (2002) · Cancer and Metastasis Reviews · doi:10.1023/a:1021254725842 · Cited by 380
THE CONVERSION OF TRYPTOPHAN TO KYNURENINE IN LIVER
Knox, W. E., & Mehler, A. H. (1950) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50967-x · Cited by 380
Indoleamine 2,3‐dioxygenase contributes to tumor cell evasion of T cell‐mediated rejection
Friberg, M., Jennings, R., Alsarraj, M., Dessureault, S., Cantor, A., Extermann, M., Mellor, A. L., Munn, D. H., & Antonia, S. J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10645 · Cited by 365
Melero, I., Johnston, J. V., Shufford, W. W., Mittler, R. S., & Chen, L. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1396 · Cited by 363
Immune escape as a fundamental trait of cancer: focus on IDO
Prendergast, G. C. (2008) · Oncogene · doi:10.1038/onc.2008.35 · Cited by 325
4-1BB-mediated immunotherapy of rheumatoid arthritis
Seo, S. K., Choi, J. H., Kim, Y. H., Kang, W. J., Park, H. Y., Suh, J. H., Choi, B. K., Vinay, D. S., & Kwon, B. S. (2004) · Nature Medicine · doi:10.1038/nm1107 · Cited by 325
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy
Grohmann, U., Volpi, C., Fallarino, F., Bozza, S., Bianchi, R., Vacca, C., Orabona, C., Belladonna, M. L., Ayroldi, E., Nocentini, G., et al. (2007) · Nature Medicine · doi:10.1038/nm1563 · Cited by 318
Löb, S., Königsrainer, A., Zieker, D., Brücher, B. L. D. M., Rammensee, H.-G., Opelz, G., & Terness, P. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0513-6 · Cited by 304
Self-citationCD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86
Orabona, C., Grohmann, U., Belladonna, M. L., Fallarino, F., Vacca, C., Bianchi, R., Bozza, S., Volpi, C., Salomon, B. L., Fioretti, M. C., et al. (2004) · Nature Immunology · doi:10.1038/ni1124 · Cited by 302
Mellor, A. L., Baban, B., Chandler, P. R., Manlapat, A., Kahler, D. J., & Munn, D. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5601 · Cited by 290
Tryptophan Pyrrolase of Rabbit Intestine
Yamamoto, S., & Hayaishi, O. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99420-2 · Cited by 289
Cady, S. G., & Sono, M. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90142-6 · Cited by 285
Baban, B., Chandler, P., McCool, D., Marshall, B., Munn, D. H., & Mellor, A. L. (2004) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2003.11.003 · Cited by 274
Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer
Ino, K., Yoshida, N., Kajiyama, H., Shibata, K., Yamamoto, E., Kidokoro, K., Takahashi, N., Terauchi, M., Nawa, A., Nomura, S., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603477 · Cited by 248
Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial
Windbichler, G. H., Hausmaninger, H., Stummvoll, W., Graf, A. H., Kainz, C., Lahodny, J., Denison, U., Müller-Holzner, E., & Marth, C. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1053 · Cited by 241
Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma.
Ozaki, Y., Edelstein, M. P., & Duch, D. S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1242 · Cited by 240
Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection.
Yoshida, R., Urade, Y., Tokuda, M., & Hayaishi, O. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.4084 · Cited by 211
T Cell Apoptosis by Kynurenines
Fallarino, F., Grohmann, U., Vacca, C., Orabona, C., Spreca, A., Fioretti, M. C., & Puccetti, P. (2003) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0135-0_21 · Cited by 204
Decreased Serum Tryptophan Concentration Predicts Poor Prognosis in Malignant Melanoma Patients
Weinlich, G., Murr, C., Richardsen, L., Winkler, C., & Fuchs, D. (2007) · Dermatology · doi:10.1159/000096906 · Cited by 197
Ge, K., DuHadaway, J., Du, W., Herlyn, M., Rodeck, U., & Prendergast, G. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9689 · Cited by 195
Zou, J.-P., Yamamoto, N., Fujii, T., Takenaka, H., Kobayashi, M., Herrmann, S. H., Wolf, S. F., Fujiwara, H., & Hamaoka, T. (1995) · International Immunology · doi:10.1093/intimm/7.7.1135 · Cited by 195
Structure−Activity Study of Brassinin Derivatives as Indoleamine 2,3-Dioxygenase Inhibitors
Gaspari, P., Banerjee, T., Malachowski, W. P., Muller, A. J., Prendergast, G. C., DuHadaway, J., Bennett, S., & Donovan, A. M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0508888 · Cited by 182
Yoshida, R., & Hayaishi, O. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.3998 · Cited by 181
Hayashi, T., Mo, J.-H., Gong, X., Rossetto, C., Jang, A., Beck, L., Elliott, G. I., Kufareva, I., Abagyan, R., Broide, D. H., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709261104 · Cited by 179
Baban, B., Hansen, A. M., Chandler, P. R., Manlapat, A., Bingaman, A., Kahler, D. J., Munn, D. H., & Mellor, A. L. (2005) · International Immunology · doi:10.1093/intimm/dxh271 · Cited by 178
Banerjee, T., DuHadaway, J. B., Gaspari, P., Sutanto-Ward, E., Munn, D. H., Mellor, A. L., Malachowski, W. P., Prendergast, G. C., & Muller, A. J. (2008) · Oncogene · doi:10.1038/sj.onc.1210939 · Cited by 175
Systemic application of CpG‐rich DNA suppresses adaptive T cell immunity via induction of IDO
Wingender, G., Garbi, N., Schumak, B., Jüngerkes, F., Endl, E., von Bubnoff, D., Steitz, J., Striegler, J., Moldenhauer, G., Tüting, T., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200535602 · Cited by 170
Riesenberg, R., Weiler, C., Spring, O., Eder, M., Buchner, A., Popp, T., Castro, M., Kammerer, R., Takikawa, O., Hatz, R. A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0942 · Cited by 170
Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma
Pan, K., Wang, H., Chen, M.-S., Zhang, H.-K., Weng, D.-S., Zhou, J., Huang, W., Li, J.-J., Song, H.-F., & Xia, J.-C. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0395-1 · Cited by 169
Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells
Lob, S., Konigsrainer, A., Schafer, R., Rammensee, H.-G., Opelz, G., & Terness, P. (2008) · Blood · doi:10.1182/blood-2007-10-116111 · Cited by 167
Self-citationCutting Edge: Autocrine TGF-β Sustains Default Tolerogenesis by IDO-Competent Dendritic Cells
Belladonna, M. L., Volpi, C., Bianchi, R., Vacca, C., Orabona, C., Pallotta, M. T., Boon, L., Gizzi, S., Fioretti, M. C., Grohmann, U., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5194 · Cited by 164
Structure Based Development of Phenylimidazole-Derived Inhibitors of Indoleamine 2,3-Dioxygenase
Kumar, S., Jaller, D., Patel, B., LaLonde, J. M., DuHadaway, J. B., Malachowski, W. P., Prendergast, G. C., & Muller, A. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800512z · Cited by 150
Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti
Suzuki, S., Toné, S., Takikawa, O., 俊一, 久., Kohno, I., & Minatogawa, Y. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3550425 · Cited by 135
Evolution of Vertebrate Indoleamine 2,3-Dioxygenases
Yuasa, H., Takubo, M., Takahashi, A., Hasegawa, T., Noma, H., & Suzuki, T. (2007) · Journal of Molecular Evolution · doi:10.1007/s00239-007-9049-1 · Cited by 134
Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications
Huang, C., Li, M., Chen, C., & Yao, Q. C. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.5.637 · Cited by 130
Brastianos, H. C., Vottero, E., Patrick, B. O., van Soest, R. W. M., Matainaho, T. K., Mauk, A. G., & Andersen, R. J. (2006) · Journal of the American Chemical Society · doi:10.1021/ja067211+ · Cited by 127
Zhang, Y., Kang, S. A., Mukherjee, T., Bale, S., Crane, B. R., Begley, T. P., & Ealick, S. E. (2006) · Biochemistry · doi:10.1021/bi0620095 · Cited by 124
Studien über den intermediären Stoffwechsel des Tryptophans XVIII—XXIV.
Kotake, Y. (1936) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1936.243.6.237 · Cited by 123
May, K. F., Chen, L., Zheng, P., & Liu, Y. (2002) · PubMed · Cited by 122
Kudo, Y., & Boyd, C. A. R. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0405i.x · Cited by 121
Nucleic Acids as Therapeutic Agents
Álvarez-Salas, L. M. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608786141133 · Cited by 119
Exploring the mechanism of tryptophan 2,3-dioxygenase
Thackray, S. J., Mowat, C. G., & Chapman, S. K. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361120 · Cited by 115
Regulation of indoleamine 2,3-dioxygenase activity in the small intestine and the epididymis of mice
Yoshida, R., Nukiwa, T., Watanabe, Y., Fujiwara, M., Hirata, F., & Hayaishi, O. (1980) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(80)90185-x · Cited by 114
Pattern of Recruitment of Immunoregulatory Antigen-Presenting Cells in Malignant Melanoma
Lee, J. R., Dalton, R. R., Messina, J. L., Sharma, M. D., Smith, D., Burgess, R. E., Mazzella, F. M., Antonia, S. J., Mellor, A. L., & Munn, D. H. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000090158.68852.d1 · Cited by 114
Neopterin Is an Independent Prognostic Variable in Females with Breast Cancer
Murr, C., Bergant, A. M., Widschwendter, M., Heim, K., Schröcksnadel, H., & Fuchs, D. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.11.1998 · Cited by 106
Beutelspacher, S. C., Tan, P., McClure, M. O., Larkin, F., Ri, L., & George, A. J. T. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01324.x · Cited by 99
Zheng, X., Koropatnick, J. D., Li, M., Zhang, X., Ling, F., Ren, X., Hao, X., Sun, H., Vladau, C., Franek, J. A., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5639 · Cited by 98
Loss of heterozygosity and tumor suppressor activity ofBin1 in prostate carcinoma
Ge, K., Minhas, F., DuHadaway, J. B., Mao, N.-C., Wilson, D. M., Buccafusca, R., Sakamuro, D., Nelson, P. S., Malkowicz, S. B., Tomaszewski, J., et al. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000415)86:2<155::aid-ijc2>3.0.co;2-m · Cited by 97
Takao, M., Okamoto, A., Nikaido, T., Urashima, M., Takakura, S., Saito, M., Saito, M., Okamoto, S., Takikawa, O., Sasaki, H., et al. (2007) · Oncology Reports · doi:10.3892/or.17.6.1333 · Cited by 97
Terness, P., Chuang, J.-J., Bauer, T. M., Jiga, L. P., & Opelz, G. (2004) · Blood · doi:10.1182/blood-2004-06-2103 · Cited by 94
Self-citationGe, K., DuHadaway, J. B., Sakamuro, D., Wechsler‐Reya, R. J., Reynolds, C. A., & Prendergast, G. C. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000201)85:3<376::aid-ijc14>3.0.co;2-1 · Cited by 92
Melichar, B., Solichová, D., & Freedman, R. S. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00294.x · Cited by 92
Immunoactivative role of indoleamine 2,3‐dioxygenase in human hepatocellular carcinoma
Ishio, T., Goto, S., Tahara, K., Toné, S., Kawano, K., & Kitano, S. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2003.03259.x · Cited by 91
Yu, W., Yamamoto, N., Takenaka, H., Mu, J., Tai, X., Zou, J.-P., Ogowa, M., Tsutsui, T., Wijesuriya, R., Yoshida, R., et al. (1996) · International Immunology · doi:10.1093/intimm/8.6.855 · Cited by 89
The immunoregulatory role of IDO-producing human dendritic cells revisited
Terness, P., Chuang, J.-J., & Opelz, G. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.12.006 · Cited by 89
Self-citationAntitumoral Activity of Interferon-γ Involved in Impaired Immune Function in Cancer Patients
Brandacher, G., Winkler, C., Schroecksnadel, K., Margreiter, R., & Fuchs, D. (2006) · Current Drug Metabolism · doi:10.2174/138920006778017768 · Cited by 89
Indoleamine 2,3-Dioxygenase Inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata
Pereira, A. R., Vottero, E., Roberge, M., Mauk, A. G., & Andersen, R. J. (2006) · Journal of Natural Products · doi:10.1021/np060111x · Cited by 88
Synthesis of Indoleamine 2,3-Dioxygenase Inhibitory Analogues of the Sponge Alkaloid Exiguamine A
Carr, G., Chung, M. K. W., Mauk, A. G., & Andersen, R. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800143h · Cited by 87
Agaugué, S., Perrin‐Cocon, L., Coutant, F., André, P., & Lotteau, V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2061 · Cited by 87
Discrimination between D- and L-tyrosyl transfer ribonucleic acids in peptide chain elongation
Yamane, T., Miller, D. L., & Hopfield, J. J. (1981) · Biochemistry · doi:10.1021/bi00528a001 · Cited by 83
Identification of Tryptophan 2,3‐Dioxygenase RNA in Rodent Brain
Haber, R., Bessette, D., Hulihan-Giblin, B. A., Durcan, M. J., & Goldman, D. A. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03269.x · Cited by 81
Tryptophan degradation in transplanted tumor cells undergoing rejection.
Yoshida, R., Park, S. W., Yasui, H., et al. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.8.2819 · Cited by 78
Fallarino, F., Orabona, C., Vacca, C., Bianchi, R., Gizzi, S., Asselin‐Paturel, C., Fioretti, M. C., Trinchieri, G., Grohmann, U., & Puccetti, P. (2005) · International Immunology · doi:10.1093/intimm/dxh321 · Cited by 76
Giannopoulos, A., Constantinides, C. A., Fokaeas, E., Stravodimos, C., Giannopoulou, M., Kyroudi, A., & Gounaris, A. (2003) · PubMed · Cited by 75
Choi, B. K., Asai, T., Vinay, D. S., Kim, Y. H., & Kwon, B. S. (2006) · Cytokine · doi:10.1016/j.cyto.2006.04.008 · Cited by 73
Britan, A., Maffre, V., Toné, S., & Drevet, J. R. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0151-7 · Cited by 69
Bin1 Ablation Increases Susceptibility to Cancer during Aging, Particularly Lung Cancer
Chang, M. Y., Boulden, J., Katz, J. B., Wang, L., Meyer, T. J., Soler, A. P., Muller, A. J., & Prendergast, G. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1100 · Cited by 67
Combined Effect of Antiretroviral Therapy and Blockade of IDO in SIV-Infected Rhesus Macaques
Boasso, A., Vaccari, M., Fuchs, D., Hardy, A. W., Tsai, W.-P., Tryniszewska, E. A., Shearer, G. M., & Franchini, G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803314 · Cited by 67
Dalmay, T. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01926.x · Cited by 64
Anti-CD137 Antibodies in the Treatment of Autoimmune Disease and Cancer
Mittler, R. S., Foell, J. L., McCausland, M. M., Strahotin, S., Niu, L., Bapat, A. S., & Hewes, L. B. (2004) · Immunologic Research · doi:10.1385/ir:29:1-3:197 · Cited by 62
Tajiri, T., Liu, X., Thompson, P. M., Tanaka, S., Suita, S., Zhao, H., Maris, J. M., Prendergast, G. C., & Hogarty, M. D. (2003) · PubMed · Cited by 61
Toll‐like receptor 9‐mediated induction of the immunosuppressive pathway of tryptophan catabolism
Fallarino, F., & Puccetti, P. (2005) · European Journal of Immunology · doi:10.1002/eji.200535667 · Cited by 60
Induction of Tryptophan 2,3-Dioxygenase in the Mouse Endometrium during Implantation
Tatsumi, K., Higuchi, T., Fujiwara, H., Nakayama, T., Egawa, H., Itoh, K., Fujii, S., & Fujita, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3115 · Cited by 55
Bcl-2-Targeted Antisense Therapy (Oblimersen Sodium): Towards Clinical Reality
Moreira, J. N., Santos, A. O., & Simões, S. (2006) · Reviews on Recent Clinical Trials · doi:10.2174/157488706778250050 · Cited by 55
Bin1 Ablation in Mammary Gland Delays Tissue Remodeling and Drives Cancer Progression
Chang, M. Y., Boulden, J., Sutanto‐Ward, E., DuHadaway, J. B., Soler, A. P., Muller, A. J., & Prendergast, G. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2742 · Cited by 47
Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase
Molano, A., Illarionov, P. A., Besra, G. S., Putterman, C., & Porcelli, S. A. (2008) · Immunology Letters · doi:10.1016/j.imlet.2007.12.013 · Cited by 47
Rosmarinic acid inhibits indoleamine 2,3-dioxygenase expression in murine dendritic cells
Lee, H. J., Jeong, Y.-I., Lee, T.-H., Jung, I. D., Lee, J. S., Lee, C.-M., Kim, J., Joo, H. Y., Lee, J.-D., & Park, Y. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.12.018 · Cited by 46
Jeong, Y.-I., Jung, I. D., Lee, J. S., Lee, C.-M., Lee, J.-D., & Park, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.076 · Cited by 45
López, A. S., Alegre, E., Díaz, A. A., Mugueta, C., & González, Á. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.05.008 · Cited by 35
Transcriptional regulation of indoleamine 2,3-dioxygenase (IDO) by tryptophan and its analogue
Okamoto, T., Toné, S., Kanouchi, H., Miyawaki, C., Ono, S., & Minatogawa, Y. (2007) · Cytotechnology · doi:10.1007/s10616-007-9081-4 · Cited by 30
RNA interference: ready to silence cancer?
D, S. M. M., Costa, R., & Nitti, D. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0709-6 · Cited by 29
Tryptophan Pyrrole Ring Cleavage Enzymes in Placenta
Minatogawa, Y., Suzuki, S., Ando, Y., Toné, S., & Takikawa, O. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0135-0_50 · Cited by 27
The Therapeutic Potential of 4-1BB (CD137) in Cancer
Nam, K.-O., Kang, W., Kwon, B., Kim, S., & Lee, H.-W. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009054629681 · Cited by 21
b, S. L. O., Ebner, S., Wagner, S., Weinreich, J., fer, R. S. A., & nigsrainer, A. K. (2007) · Transplantation · doi:10.1097/01.tp.0000251646.09702.ec · Cited by 21
p-Coumaric acid inhibits indoleamine 2, 3-dioxygenase expression in murine dendritic cells
Kim, S.-I., Jeong, Y.-I., Jung, I. D., Lee, J. S., Lee, C.-M., Yoon, M., Seong, E.-Y., Kim, J., Lee, J.-D., & Park, Y. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.01.020 · Cited by 19
Cited by
Natural Innate and Adaptive Immunity to Cancer
Vesely, M. D., Kershaw, M. H., Schreiber, R. D., & Smyth, M. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101324 · Cited by 2,101
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Platten, M., Nollen, E. A. A., Röhrig, U. F., Fallarino, F., & Opitz, C. A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0016-5 · Cited by 1,586
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways
Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0026 · Cited by 899
Metadata
- Authors
- Löb, S., Königsrainer, A., Rammensee, H.-G., Opelz, G., & Terness, P.
- Venue
- Nature Reviews Cancer
- Published
- 2009-06
- Volume
- 9
- Issue
- 6
- Pages
- 445-452
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2050779943
- Cited by
- 421
- References
- 122
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.